Project Grant R35GM161793
- Federal Grant Award Summary Duke University's Office of Research Administration received a $401,233 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025 through May 31, 2030. The award supports the development of novel amination methods and strategies for chemical synthesis, specifically focused on creating new catalytic selective amination reactions and...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $150,104 Project Grant to UCLA's Office of Research Administration on March 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports research titled "Data-Science Guided Study and Design of Phosphoranyl Radical-Mediated Reactions," with completion scheduled for August 31, 2028. The research develops machine learning predictive models to...
- Federal Project Grant Award Summary The National Science Foundation's Division of Chemistry awarded Rice University $550,000 under the Mathematical and Physical Sciences (CFDA 47.049) program on June 15, 2025, to support Professor Hans Renata's research on chemoenzymatic total synthesis of complex terpenoid natural products through May 31, 2028. The research develops hybrid synthetic strategies combining enzymatic catalysis with modern organic chemistry methodologies to efficiently synthesize...
- Grant Award Summary Rice University, through its Office of Sponsored Projects, received a $400,000 Project Grant from the National Science Foundation (NSF) Division of Chemistry under the Mathematical and Physical Sciences program (CFDA 47.049), effective September 1, 2025, through August 31, 2028. Under the direction of Professor László Kérti, the award funds research focused on developing innovative synthetic chemistry reactions for constructing nitrogen-containing heterocycles by leveraging...
- Federal Grant Award Summary The National Institute of General Medical Sciences awarded a $125,000 Project Grant to Harvard College's Office for Sponsored Programs, effective February 1, 2026 through January 31, 2028, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports fundamental research in synthetic organic chemistry focused on developing catalytic, enantioselective hydrochlorination reactions of alkenes. The research deliverables include...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Harvard College $150,104 under the Biomedical Research and Research Training program (CFDA 93.859) to support fundamental research in synthetic chemistry. The project, which commenced June 22, 2026 and concludes February 28, 2029, focuses on developing selective N-alkylation methods for azoles through anion-binding catalysis. This research addresses a significant synthetic challenge in medicinal...
- Federal Project Grant Award Summary Award Details: The National Institute of General Medical Sciences (NIGMS) awarded a $552,403 Project Grant to Columbia University under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, with a completion date of August 31, 2030. Principal Investigator Tomislav Rovis will direct research on "Selective Transformations of Common Feedstocks to Functionalized Amines and Heterocycles." Research Scope: This...
- Federal Grant Award Summary The University of Minnesota received a $249,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2028. The award supports fundamental research focused on developing novel methods for radical hydroamination via boryl radical chemistry. The research deliverables encompass two primary objectives: (1) the discovery and...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of California, Berkeley a Project Grant of $226,560 under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026 through December 30, 2028. The award supports research focused on developing novel catalytic methods to synthesize saturated, nitrogen-containing heterocycles guided by mechanism-aware machine learning models. These heterocyclic...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $433,780 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to develop innovative chemical reactions advancing drug discovery. The award, effective April 1, 2026, through March 31, 2031, supports two complementary research directions: (1) the development of stereoselective catalytic reactions to...
Rice University received a $410,184 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026, with completion targeted for January 31, 2031. The award supports a five-year fundamental research program focused on developing innovative synthetic chemistry methods for nitrogen-containing compounds, specifically targeting streamlined synthesis of N-unprotected chiral heterocycles and amines through organocatalytic and transition metal catalytic approaches. This research addresses critical gaps in synthetic organic chemistry that limit the ability to efficiently incorporate nitrogen into pharmaceutical, agrochemical, and materials science applications. The research deliverables include the development of three mechanistically distinct amination strategies: (1) catalyst-free olefin difunctionalization methods utilizing N-acyl-N-halo-O-sulfonyl hydroxylamines to enable direct halo-hydroxylamination of feedstock olefins; (2) photochemical and chiral acid-catalyzed aziridination processes to expand the scope of nitrogen transfer to isolated and conjugated olefins; and (3) additional nitrogen-transfer methodologies leveraging novel mechanistic approaches. These synthetic advances are intended to facilitate the rapid exploration of nitrogen-rich chemical spaces critical for developing next-generation pharmaceuticals and biologically active compounds, thereby advancing fundamental knowledge in synthetic chemistry with applications across multiple industries.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $410.2k | 3/2/26 |